Junko Morita

Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia

Autoimmune Thyroid Diseases in 65 Japanese Women with Turner Syndrome

Metabolic Co-Morbidities Revealed in Patients with Childhood-Onset Adult GH Deficiency after Cessation of GH Replacement Therapy for Short Stature

Growth Hormone (GH) or Insulin-like Growth Factor (IGF)-I Represses 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1) mRNA Expression in 3T3-L1 Cells and Its Activity in Their Homogenates

P-25 The influences of the standardization of GH assay on the criteria for evaluating the effect of treatment of acromegaly in Japan

P-75 SERUM INSULIN-LIKE GROWTH FACTOR-I (IGF-I) LEVELS IN ACROMEGALIC PATIENTS WITH APPARENTLY NORMAL GH LEVELS

OR05-4 SERUM LEVELS OF HIGH MOLECULAR WEIGHT FORM OF ADIPONECTIN IN 60 PATIENTS WITH ADULT GROWTH HORMONE DEFICIENCY

OR07-2 METABOLIC COMPLICATIONS REVEALED IN 42 PATIENTS WITH CHILDHOOD-ONSET ADULT GH DEFICIENCY AFTER THE CESSATION OF GH REPLACEMENT THERAPY FOR SHORT STATURE

P-65 CLINICAL CHARACTERISTICS OF ADULT GROWTH HORMONE DEFICIENCY WITH NON-ALCOHOLIC FATTY LIVER DISEASE

P-77 THE ROLE OF INSULIN-LIKE-GROWTH FACTOR I (IGF-I) IN GLUCOSE INTOLERANCE IN THE PATIENTS WITH ACROMEGALY